MiR-155: Difference between revisions

Edit links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
added boxes.
Line 1: Line 1:
{{Infobox rfam
| Name = mir-155
| image =
| width =
| caption =
| Symbol = mir-155
| AltSymbols =
| Rfam = RF00731
| miRBase_family = MIPF0000157
| RNA_type = [[microRNA]]
| Tax_domain = ''[[Eukaryote|Eukaryota]];''
| HGNCid =
| OMIM =
}}


In molecular biology, '''mir-155 microRNA''' is a short [[non-coding RNA|RNA]] molecule. [[MicroRNA]]s function to regulate the expression levels of other genes by a several mechanisms.
In molecular biology, '''mir-155 microRNA''' is a short [[non-coding RNA|RNA]] molecule. [[MicroRNA]]s function to regulate the expression levels of other genes by a several mechanisms.


== See also ==
* [[MicroRNA]]

==Further reading==
<div style='display:none'>
<ref name="pmid21030878">{{cite journal |author=Huang RS, Hu GQ, Lin B, Lin ZY, Sun CC |title=MicroRNA-155 Silencing Enhances Inflammatory Response and Lipid Uptake in Oxidized Low-Density Lipoprotein-Stimulated Human THP-1 Macrophages. |journal=J Investig Med |volume= |issue= |pages= |year=2010 |pmid=21030878}}</ref>
<ref name="pmid20966899">{{cite journal |author=Ceolotto G, Papparella I, Bortoluzzi A, Strapazzon G, Ragazzo F, Bratti P, Fabricio AS, Squarcina E, Gion M, Palatini P, Semplicini A |title=Interplay Between miR-155, AT1R A1166C Polymorphism, and AT1R Expression in Young Untreated Hypertensives. |journal=Am J Hypertens |volume= |issue= |pages= |year=2010 |pmid=20966899}}</ref>
<ref name="pmid20952466">{{cite journal |author=Wang G, Tam LS, Li EK, Kwan BC, Chow KM, Luk CC, Li PK, Szeto CC |title=Serum and Urinary Cell-free MiR-146a and MiR-155 in Patients with Systemic Lupus Erythematosus. |journal=J Rheumatol |volume= |issue= |pages= |year=2010 |pmid=20952466}}</ref>
<ref name="pmid20950585">{{cite journal |author=Kutty RK, Nagineni CN, Samuel W, Vijayasarathy C, Hooks JJ, Redmond TM |title=Inflammatory cytokines regulate microRNA-155 expression in human retinal pigment epithelial cells by activating JAK/STAT pathway. |journal=Biochem Biophys Res Commun |volume= |issue= |pages= |year=2010 |pmid=20950585}}</ref>
<ref name="pmid20948191">{{cite journal |author=Imaizumi T, Tanaka H, Tajima A, Yokono Y, Matsumiya T, Yoshida H, Tsuruga K, Aizawa-Yashiro T, Hayakari R, Inoue I, Ito E, Satoh K |title=IFN-γ and TNF-α Synergistically Induce microRNA-155 Which Regulates TAB2/IP-10 Expression in Human Mesangial Cells. |journal=Am J Nephrol |volume=32 |issue=5 |pages=462-468 |year=2010 |pmid=20948191}}</ref>
<ref name="pmid20947507">{{cite journal |author=Thompson RC, Herscovitch M, Zhao I, Ford TJ, Gilmore TD |title=NF-{kappa}B down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway. |journal=J Biol Chem |volume= |issue= |pages= |year=2010 |pmid=20947507}}</ref>
<ref name="pmid20937844">{{cite journal |author=Wang P, Hou J, Lin L, Wang C, Liu X, Li D, Ma F, Wang Z, Cao X |title=Inducible microRNA-155 Feedback Promotes Type I IFN Signaling in Antiviral Innate Immunity by Targeting Suppressor of Cytokine Signaling 1. |journal=J Immunol |volume= |issue= |pages= |year=2010 |pmid=20937844}}</ref>
<ref name="pmid20888269">{{cite journal |author=O'Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, Chaudhuri AA, Kahn ME, Rao DS, Baltimore D |title=MicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell Development. |journal=Immunity |volume=33 |issue=4 |pages=607-19 |year=2010 |pmid=20888269}}</ref>
<ref name="pmid20871480">{{cite journal |author=Xia QS, Ishigaki Y, Zhao X, Shimasaki T, Nakajima H, Nakagawa H, Takegami T, Chen ZH, Motoo Y |title=Human SMG-1 is Involved in Gemcitabine-Induced Primary microRNA-155/BIC Up-Regulation in Human Pancreatic Cancer PANC-1 Cells. |journal=Pancreas |volume= |issue= |pages= |year=2010 |pmid=20871480}}</ref>
<ref name="pmid20852130">{{cite journal |author=Zhou H, Huang X, Cui H, Luo X, Tang Y, Chen S, Wu L, Shen N |title=miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. |journal=Blood |volume= |issue= |pages= |year=2010 |pmid=20852130}}</ref>
<ref name="pmid20844043">{{cite journal |author=Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR |title=Virally Induced Cellular MicroRNA miR-155 Plays a Key Role in B-Cell Immortalization by Epstein-Barr Virus. |journal=J Virol |volume=84 |issue=22 |pages=11670-8 |year=2010 |pmid=20844043}}</ref>
<ref name="pmid20735984">{{cite journal |author=Zheng L, Xu CC, Chen WD, Shen WL, Ruan CC, Zhu LM, Zhu DL, Gao PJ |title=MicroRNA-155 regulates angiotensin II type 1 receptor expression and phenotypic differentiation in vascular adventitial fibroblasts. |journal=Biochem Biophys Res Commun |volume=400 |issue=4 |pages=483-8 |year=2010 |pmid=20735984}}</ref>
<ref name="pmid20673989">{{cite journal |author=Sonkoly E, Janson P, Majuri ML, Savinko T, Fyhrquist N, Eidsmo L, Xu N, Meisgen F, Wei T, Bradley M, Stenvang J, Kauppinen S, Alenius H, Lauerma A, Homey B, Winqvist O, Ståhle M, Pivarcsi A |title=MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. |journal=J Allergy Clin Immunol |volume=126 |issue=3 |pages=581-9.e1-20 |year=2010 |pmid=20673989}}</ref>
<ref name="pmid20622002">{{cite journal |author=Tili E, Michaille JJ, Adair B, Alder H, Limagne E, Taccioli C, Ferracin M, Delmas D, Latruffe N, Croce CM |title=Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. |journal=Carcinogenesis |volume=31 |issue=9 |pages=1561-6 |year=2010 |pmid=20622002}}</ref>
<ref name="pmid20579867">{{cite journal |author=Boesch-Saadatmandi C, Loboda A, Wagner AE, Stachurska A, Jozkowicz A, Dulak J, Döring F, Wolffram S, Rimbach G |title=Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. |journal=J Nutr Biochem |volume= |issue= |pages= |year=2010 |pmid=20579867}}</ref>
<ref name="pmid20550618">{{cite journal |author=Liu J, van Mil A, Vrijsen K, Zhao J, Gao L, Goumans MJ, Doevendans PA, Sluijter JP |title=MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1. |journal=J Cell Mol Med |volume= |issue= |pages= |year=2010 |pmid=20550618}}</ref>
<ref name="pmid20548288">{{cite journal |author=Pogribny IP, Starlard-Davenport A, Tryndyak VP, Han T, Ross SA, Rusyn I, Beland FA |title=Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. |journal=Lab Invest |volume=90 |issue=10 |pages=1437-46 |year=2010 |pmid=20548288}}</ref>
<ref name="pmid20452491">{{cite journal |author=Zhang Y, Diao Z, Su L, Sun H, Li R, Cui H, Hu Y |title=MicroRNA-155 contributes to preeclampsia by down-regulating CYR61. |journal=Am J Obstet Gynecol |volume=202 |issue=5 |pages=466.e1-7 |year=2010 |pmid=20452491}}</ref>
<ref name="pmid20444872">{{cite journal |author=Hu YL, Fong S, Largman C, Shen WF |title=HOXA9 regulates miR-155 in hematopoietic cells. |journal=Nucleic Acids Res |volume=38 |issue=16 |pages=5472-8 |year=2010 |pmid=20444872}}</ref>
<ref name="pmid20435894">{{cite journal |author=McCoy CE, Sheedy FJ, Qualls JE, Doyle SL, Quinn SR, Murray PJ, O'Neill LA |title=IL-10 inhibits miR-155 induction by toll-like receptors. |journal=J Biol Chem |volume=285 |issue=27 |pages=20492-8 |year=2010 |pmid=20435894}}</ref>
<ref name="pmid20427544">{{cite journal |author=Yin Q, Wang X, Fewell C, Cameron J, Zhu H, Baddoo M, Lin Z, Flemington EK |title=MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivation. |journal=J Virol |volume=84 |issue=13 |pages=6318-27 |year=2010 |pmid=20427544}}</ref>
<ref name="pmid20388420">{{cite journal |author=Zhu J, Hu XQ, Guo GL, Zhang Y, Wang OC, You J, Huang QD, Zhang XH |title=[Expression and its clinical significance of miR-155 in human primary breast cancer.] |journal=Zhonghua Wai Ke Za Zhi |volume=48 |issue=3 |pages=205-8 |year=2010 |pmid=20388420}}</ref>
<ref name="pmid20371610">{{cite journal |author=Kong W, He L, Coppola M, Guo J, Esposito NN, Coppola D, Cheng JQ |title=MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. |journal=J Biol Chem |volume=285 |issue=23 |pages=17869-79 |year=2010 |pmid=20371610}}</ref>
<ref name="pmid20356498">{{cite journal |author=Xia QS, Ishigaki Y, Sun L, Chen R, Motoo Y |title=[Effect of anti-cancer drugs on the expression of BIC/miR-155 in human pancreatic cancer PANC-1 cells] |journal=Zhonghua Yi Xue Za Zhi |volume=90 |issue=2 |pages=123-7 |year=2010 |pmid=20356498}}</ref>
<ref name="pmid20354188">{{cite journal |author=Jiang S, Zhang HW, Lu MH, He XH, Li Y, Gu H, Liu MF, Wang ED |title=MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. |journal=Cancer Res |volume=70 |issue=8 |pages=3119-27 |year=2010 |pmid=20354188}}</ref>
<ref name="pmid20351277">{{cite journal |author=Valeri N, Gasparini P, Fabbri M, Braconi C, Veronese A, Lovat F, Adair B, Vannini I, Fanini F, Bottoni A, Costinean S, Sandhu SK, Nuovo GJ, Alder H, Gafa R, Calore F, Ferracin M, Lanza G, Volinia S, Negrini M, McIlhatton MA, Amadori D, Fishel R, Croce CM |title=Modulation of mismatch repair and genomic stability by miR-155. |journal=Proc Natl Acad Sci U S A |volume=107 |issue=15 |pages=6982-7 |year=2010 |pmid=20351277}}</ref>
<ref name="pmid20332664">{{cite journal |author=Ryu JK, Hong SM, Karikari CA, Hruban RH, Goggins MG, Maitra A |title=Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma. |journal=Pancreatology |volume=10 |issue=1 |pages=66-73 |year=2010 |pmid=20332664}}</ref>
<ref name="pmid20223773">{{cite journal |author=Fabani MM, Abreu-Goodger C, Williams D, Lyons PA, Torres AG, Smith KG, Enright AJ, Gait MJ, Vigorito E |title=Efficient inhibition of miR-155 function in vivo by peptide nucleic acids. |journal=Nucleic Acids Res |volume=38 |issue=13 |pages=4466-75 |year=2010 |pmid=20223773}}</ref>
<ref name="pmid20219467">{{cite journal |author=Tang B, Xiao B, Liu Z, Li N, Zhu ED, Li BS, Xie QH, Zhuang Y, Zou QM, Mao XH |title=Identification of MyD88 as a novel target of miR-155, involved in negative regulation of Helicobacter pylori-induced inflammation. |journal=FEBS Lett |volume=584 |issue=8 |pages=1481-6 |year=2010 |pmid=20219467}}</ref>
<ref name="pmid20209161">{{cite journal |author=Fassi Fehri L, Koch M, Belogolova E, Khalil H, Bolz C, Kalali B, Mollenkopf HJ, Beigier-Bompadre M, Karlas A, Schneider T, Churin Y, Gerhard M, Meyer TF |title=Helicobacter pylori induces miR-155 in T cells in a cAMP-Foxp3-dependent manner. |journal=PLoS One |volume=5 |issue=3 |pages=e9500 |year=2010 |pmid=20209161}}</ref>
<ref name="pmid20201617">{{cite journal |author=Sidorkiewicz M, Grek M, Jozwiak B, Majda-Stanislawska E, Piekarska A, Bartkowiak J |title=Expression of microRNA-155 precursor in peripheral blood mononuclear cells from Hepatitis C patients after antiviral treatment. |journal=Acta Virol |volume=54 |issue=1 |pages=75-8 |year=2010 |pmid=20201617}}</ref>
<ref name="pmid20170545">{{cite journal |author=Gueta K, Molotski N, Gerchikov N, Mor E, Savion S, Fein A, Toder V, Shomron N, Torchinsky A |title=Teratogen-induced alterations in microRNA-34, microRNA-125b and microRNA-155 expression: correlation with embryonic p53 genotype and limb phenotype. |journal=BMC Dev Biol |volume=10 |issue= |pages=20 |year=2010 |pmid=20170545}}</ref>
<ref name="pmid20133617">{{cite journal |author=Rai D, Kim SW, McKeller MR, Dahia PL, Aguiar RC |title=Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. |journal=Proc Natl Acad Sci U S A |volume=107 |issue=7 |pages=3111-6 |year=2010 |pmid=20133617}}</ref>
<ref name="pmid20041145">{{cite journal |author=Cremer TJ, Ravneberg DH, Clay CD, Piper-Hunter MG, Marsh CB, Elton TS, Gunn JS, Amer A, Kanneganti TD, Schlesinger LS, Butchar JP, Tridandapani S |title=MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine response. |journal=PLoS One |volume=4 |issue=12 |pages=e8508 |year=2009 |pmid=20041145}}</ref>
<ref name="pmid19956200">{{cite journal |author=Forrest AR, Kanamori-Katayama M, Tomaru Y, Lassmann T, Ninomiya N, Takahashi Y, de Hoon MJ, Kubosaki A, Kaiho A, Suzuki M, Yasuda J, Kawai J, Hayashizaki Y, Hume DA, Suzuki H |title=Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. |journal=Leukemia |volume=24 |issue=2 |pages=460-6 |year=2010 |pmid=19956200}}</ref>
<ref name="pmid19890474">{{cite journal |author=Pedersen IM, Otero D, Kao E, Miletic AV, Hother C, Ralfkiaer E, Rickert RC, Gronbaek K, David M |title=Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas. |journal=EMBO Mol Med |volume=1 |issue=5 |pages=288-95 |year=2009 |pmid=19890474}}</ref>
<ref name="pmid19887047">{{cite journal |author=He M, Xu Z, Ding T, Kuang DM, Zheng L |title=MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta. |journal=Cell Mol Immunol |volume=6 |issue=5 |pages=343-52 |year=2009 |pmid=19887047}}</ref>
<ref name="pmid19811312">{{cite journal |author=Tili E, Croce CM, Michaille JJ |title=miR-155: on the crosstalk between inflammation and cancer. |journal=Int Rev Immunol |volume=28 |issue=5 |pages=264-84 |year=2009 |pmid=19811312}}</ref>
<ref name="pmid19777054">{{cite journal |author=Stahl HF, Fauti T, Ullrich N, Bopp T, Kubach J, Rust W, Labhart P, Alexiadis V, Becker C, Hafner M, Weith A, Lenter MC, Jonuleit H, Schmitt E, Mennerich D |title=miR-155 inhibition sensitizes CD4+ Th cells for TREG mediated suppression. |journal=PLoS One |volume=4 |issue=9 |pages=e7158 |year=2009 |pmid=19777054}}</ref>
<ref name="pmid19759154">{{cite journal |author=Bolisetty MT, Dy G, Tam W, Beemon KL |title=Reticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survival. |journal=J Virol |volume=83 |issue=23 |pages=12009-17 |year=2009 |pmid=19759154}}</ref>
<ref name="pmid19711427">{{cite journal |author=Wang B, Majumder S, Nuovo G, Kutay H, Volinia S, Patel T, Schmittgen TD, Croce C, Ghoshal K, Jacob ST |title=Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. |journal=Hepatology |volume=50 |issue=4 |pages=1152-61 |year=2009 |pmid=19711427}}</ref>
<ref name="pmid19701459">{{cite journal |author=Pottier N, Maurin T, Chevalier B, Puisségur MP, Lebrigand K, Robbe-Sermesant K, Bertero T, Lino Cardenas CL, Courcot E, Rios G, Fourre S, Lo-Guidice JM, Marcet B, Cardinaud B, Barbry P, Mari B |title=Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions. |journal=PLoS One |volume=4 |issue=8 |pages=e6718 |year=2009 |pmid=19701459}}</ref>
<ref name="pmid19650740">{{cite journal |author=Xiao B, Liu Z, Li BS, Tang B, Li W, Guo G, Shi Y, Wang F, Wu Y, Tong WD, Guo H, Mao XH, Zou QM |title=Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. |journal=J Infect Dis |volume=200 |issue=6 |pages=916-25 |year=2009 |pmid=19650740}}</ref>
<ref name="pmid19596814">{{cite journal |author=Worm J, Stenvang J, Petri A, Frederiksen KS, Obad S, Elmén J, Hedtjärn M, Straarup EM, Hansen JB, Kauppinen S |title=Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c/ebp Beta and down-regulation of G-CSF. |journal=Nucleic Acids Res |volume=37 |issue=17 |pages=5784-92 |year=2009 |pmid=19596814}}</ref>
<ref name="pmid19520806">{{cite journal |author=Costinean S, Sandhu SK, Pedersen IM, Tili E, Trotta R, Perrotti D, Ciarlariello D, Neviani P, Harb J, Kauffman LR, Shidham A, Croce CM |title=Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. |journal=Blood |volume=114 |issue=7 |pages=1374-82 |year=2009 |pmid=19520806}}</ref>
<ref name="pmid19423639">{{cite journal |author=Ruggiero T, Trabucchi M, De Santa F, Zupo S, Harfe BD, McManus MT, Rosenfeld MG, Briata P, Gherzi R |title=LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 precursors in macrophages. |journal=FASEB J |volume=23 |issue=9 |pages=2898-908 |year=2009 |pmid=19423639}}</ref>
<ref name="pmid19386588">{{cite journal |author=Martinez-Nunez RT, Louafi F, Friedmann PS, Sanchez-Elsner T |title=MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN). |journal=J Biol Chem |volume=284 |issue=24 |pages=16334-42 |year=2009 |pmid=19386588}}</ref>
<ref name="pmid19359473">{{cite journal |author=O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D |title=Inositol phosphatase SHIP1 is a primary target of miR-155. |journal=Proc Natl Acad Sci U S A |volume=106 |issue=17 |pages=7113-8 |year=2009 |pmid=19359473}}</ref>
<ref name="pmid19268705">{{cite journal |author=Faraoni I, Antonetti FR, Cardone J, Bonmassar E |title=miR-155 gene: a typical multifunctional microRNA. |journal=Biochim Biophys Acta |volume=1792 |issue=6 |pages=497-505 |year=2009 |pmid=19268705}}</ref>
<ref name="pmid19234151">{{cite journal |author=Kohlhaas S, Garden OA, Scudamore C, Turner M, Okkenhaug K, Vigorito E |title=Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells. |journal=J Immunol |volume=182 |issue=5 |pages=2578-82 |year=2009 |pmid=19234151}}</ref>
<ref name="pmid19193853">{{cite journal |author=Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA, Pierre P |title=MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. |journal=Proc Natl Acad Sci U S A |volume=106 |issue=8 |pages=2735-40 |year=2009 |pmid=19193853}}</ref>
<ref name="pmid19106647">{{cite journal |author=Habbe N, Koorstra JB, Mendell JT, Offerhaus GJ, Ryu JK, Feldmann G, Mullendore ME, Goggins MG, Hong SM, Maitra A |title=MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. |journal=Cancer Biol Ther |volume=8 |issue=4 |pages=340-6 |year=2009 |pmid=19106647}}</ref>
<ref name="pmid19016736">{{cite journal |author=Jung I, Aguiar RC |title=MicroRNA-155 expression and outcome in diffuse large B-cell lymphoma. |journal=Br J Haematol |volume=144 |issue=1 |pages=138-40 |year=2009 |pmid=19016736}}</ref>
<ref name="pmid19008191">{{cite journal |author=Teng G, Papavasiliou FN |title=Shhh! Silencing by microRNA-155. |journal=Philos Trans R Soc Lond B Biol Sci |volume=364 |issue=1517 |pages=631-7 |year=2009 |pmid=19008191}}</ref>
<ref name="pmid18950466">{{cite journal |author=Romania P, Lulli V, Pelosi E, Biffoni M, Peschle C, Marziali G |title=MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meis1 transcription factors. |journal=Br J Haematol |volume=143 |issue=4 |pages=570-80 |year=2008 |pmid=18950466}}</ref>
<ref name="pmid18945769">{{cite journal |author=Zhao Y, Yao Y, Xu H, Lambeth L, Smith LP, Kgosana L, Wang X, Nair V |title=A functional MicroRNA-155 ortholog encoded by the oncogenic Marek's disease virus. |journal=J Virol |volume=83 |issue=1 |pages=489-92 |year=2009 |pmid=18945769}}</ref>
<ref name="pmid18940871">{{cite journal |author=Gatto G, Rossi A, Rossi D, Kroening S, Bonatti S, Mallardo M |title=Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. |journal=Nucleic Acids Res |volume=36 |issue=20 |pages=6608-19 |year=2008 |pmid=18940871}}</ref>
<ref name="pmid18926796">{{cite journal |author=Rahadiani N, Takakuwa T, Tresnasari K, Morii E, Aozasa K |title=Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell lines. |journal=Biochem Biophys Res Commun |volume=377 |issue=2 |pages=579-83 |year=2008 |pmid=18926796}}</ref>
<ref name="pmid18794355">{{cite journal |author=Kong W, Yang H, He L, Zhao JJ, Coppola D, Dalton WS, Cheng JQ |title=MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. |journal=Mol Cell Biol |volume=28 |issue=22 |pages=6773-84 |year=2008 |pmid=18794355}}</ref>
<ref name="pmid18753206">{{cite journal |author=Lu F, Weidmer A, Liu CG, Volinia S, Croce CM, Lieberman PM |title=Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. |journal=J Virol |volume=82 |issue=21 |pages=10436-43 |year=2008 |pmid=18753206}}</ref>
<ref name="pmid18455451">{{cite journal |author=Dorsett Y, McBride KM, Jankovic M, Gazumyan A, Thai TH, Robbiani DF, Di Virgilio M, San-Martin BR, Heidkamp G, Schwickert TA, Eisenreich T, Rajewsky K, Nussenzweig MC |title=MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. |journal=Immunity |volume=28 |issue=5 |pages=630-8 |year=2008 |pmid=18455451}}</ref>
<ref name="pmid18450484">{{cite journal |author=Teng G, Hakimpour P, Landgraf P, Rice A, Tuschl T, Casellas R, Papavasiliou FN |title=MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. |journal=Immunity |volume=28 |issue=5 |pages=621-9 |year=2008 |pmid=18450484}}</ref>
<ref name="pmid18367535">{{cite journal |author=Yin Q, McBride J, Fewell C, Lacey M, Wang X, Lin Z, Cameron J, Flemington EK |title=MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. |journal=J Virol |volume=82 |issue=11 |pages=5295-306 |year=2008 |pmid=18367535}}</ref>
<ref name="pmid18354490">{{cite journal |author=Zhang T, Nie K, Tam W |title=BIC is processed efficiently to microRNA-155 in Burkitt lymphoma cells. |journal=Leukemia |volume=22 |issue=9 |pages=1795-7 |year=2008 |pmid=18354490}}</ref>
<ref name="pmid18348159">{{cite journal |author=Wang M, Tan LP, Dijkstra MK, van Lom K, Robertus JL, Harms G, Blokzijl T, Kooistra K, van T'veer MB, Rosati S, Visser L, Jongen-Lavrencic M, Kluin PM, van den Berg A |title=miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression. |journal=J Pathol |volume=215 |issue=1 |pages=13-20 |year=2008 |pmid=18348159}}</ref>
<ref name="pmid18299402">{{cite journal |author=O'Connell RM, Rao DS, Chaudhuri AA, Boldin MP, Taganov KD, Nicoll J, Paquette RL, Baltimore D |title=Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. |journal=J Exp Med |volume=205 |issue=3 |pages=585-94 |year=2008 |pmid=18299402}}</ref>
<ref name="pmid18262046">{{cite journal |author=Rai D, Karanti S, Jung I, Dahia PL, Aguiar RC |title=Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. |journal=Cancer Genet Cytogenet |volume=181 |issue=1 |pages=8-15 |year=2008 |pmid=18262046}}</ref>
<ref name="pmid18093533">{{cite journal |author=Calame K |title=MicroRNA-155 function in B Cells. |journal=Immunity |volume=27 |issue=6 |pages=825-7 |year=2007 |pmid=18093533}}</ref>
<ref name="pmid18075594">{{cite journal |author=Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi JT, Braich R, Manoharan M, Soutschek J, Ohler U, Cullen BR |title=A viral microRNA functions as an orthologue of cellular miR-155. |journal=Nature |volume=450 |issue=7172 |pages=1096-9 |year=2007 |pmid=18075594}}</ref>
<ref name="pmid18055230">{{cite journal |author=Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, Kohlhaas S, Das PP, Miska EA, Rodriguez A, Bradley A, Smith KG, Rada C, Enright AJ, Toellner KM, Maclennan IC, Turner M |title=microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. |journal=Immunity |volume=27 |issue=6 |pages=847-59 |year=2007 |pmid=18055230}}</ref>
<ref name="pmid18048365">{{cite journal |author=Yin Q, Wang X, McBride J, Fewell C, Flemington E |title=B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element. |journal=J Biol Chem |volume=283 |issue=5 |pages=2654-62 |year=2008 |pmid=18048365}}</ref>
<ref name="pmid17911593">{{cite journal |author=Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, Croce CM |title=Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. |journal=J Immunol |volume=179 |issue=8 |pages=5082-9 |year=2007 |pmid=17911593}}</ref>
<ref name="pmid17911264">{{cite journal |author=Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J, Garcia S, Nowak J, Yeung ML, Jeang KT, Chaix A, Fazli L, Motoo Y, Wang Q, Rocchi P, Russo A, Gleave M, Dagorn JC, Iovanna JL, Carrier A, Pébusque MJ, Dusetti NJ |title=Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. |journal=Proc Natl Acad Sci U S A |volume=104 |issue=41 |pages=16170-5 |year=2007 |pmid=17911264}}</ref>
<ref name="pmid17881434">{{cite journal |author=Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, Lopez MC, Baker HV, Renne R |title=Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. |journal=J Virol |volume=81 |issue=23 |pages=12836-45 |year=2007 |pmid=17881434}}</ref>
<ref name="pmid17668390">{{cite journal |author=Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS, Hatzigeorgiou AG, Antonarakis SE |title=Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. |journal=Am J Hum Genet |volume=81 |issue=2 |pages=405-13 |year=2007 |pmid=17668390}}</ref>
<ref name="pmid17588946">{{cite journal |author=Martin MM, Buckenberger JA, Jiang J, Malana GE, Nuovo GJ, Chotani M, Feldman DS, Schmittgen TD, Elton TS |title=The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microrna-155 binding. |journal=J Biol Chem |volume=282 |issue=33 |pages=24262-9 |year=2007 |pmid=17588946}}</ref>
<ref name="pmid17463290">{{cite journal |author=Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, van Dongen S, Grocock RJ, Das PP, Miska EA, Vetrie D, Okkenhaug K, Enright AJ, Dougan G, Turner M, Bradley A |title=Requirement of bic/microRNA-155 for normal immune function. |journal=Science |volume=316 |issue=5824 |pages=608-11 |year=2007 |pmid=17463290}}</ref>
<ref name="pmid17463289">{{cite journal |author=Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, Schmidt-Supprian M, Rajewsky N, Yancopoulos G, Rao A, Rajewsky K |title=Regulation of the germinal center response by microRNA-155. |journal=Science |volume=316 |issue=5824 |pages=604-8 |year=2007 |pmid=17463289}}</ref>
<ref name="pmid17242365">{{cite journal |author=O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D |title=MicroRNA-155 is induced during the macrophage inflammatory response. |journal=Proc Natl Acad Sci U S A |volume=104 |issue=5 |pages=1604-9 |year=2007 |pmid=17242365}}</ref>
<ref name="pmid16675453">{{cite journal |author=Martin MM, Lee EJ, Buckenberger JA, Schmittgen TD, Elton TS |title=MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. |journal=J Biol Chem |volume=281 |issue=27 |pages=18277-84 |year=2006 |pmid=16675453}}</ref>
<ref name="pmid16614444">{{cite journal |author=Chung KH, Hart CC, Al-Bassam S, Avery A, Taylor J, Patel PD, Vojtek AB, Turner DL |title=Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. |journal=Nucleic Acids Res |volume=34 |issue=7 |pages=e53 |year=2006 |pmid=16614444}}</ref>
<ref name="pmid16252262">{{cite journal |author=Tam W, Dahlberg JE |title=miR-155/BIC as an oncogenic microRNA. |journal=Genes Chromosomes Cancer |volume=45 |issue=2 |pages=211-2 |year=2006 |pmid=16252262}}</ref>
<ref name="pmid16235244">{{cite journal |author=Kluiver J, Haralambieva E, de Jong D, Blokzijl T, Jacobs S, Kroesen BJ, Poppema S, van den Berg A |title=Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. |journal=Genes Chromosomes Cancer |volume=45 |issue=2 |pages=147-53 |year=2006 |pmid=16235244}}</ref>
<ref name="pmid16175574">{{cite journal |author=Jiang J, Lee EJ, Schmittgen TD |title=Increased expression of microRNA-155 in Epstein-Barr virus transformed lymphoblastoid cell lines. |journal=Genes Chromosomes Cancer |volume=45 |issue=1 |pages=103-6 |year=2006 |pmid=16175574}}</ref>
<ref name="pmid16041695">{{cite journal |author=Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S, Kroesen BJ, van den Berg A |title=BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. |journal=J Pathol |volume=207 |issue=2 |pages=243-9 |year=2005 |pmid=16041695}}</ref>
<ref name="pmid15738415">{{cite journal |author=Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, Lund E, Dahlberg JE |title=Accumulation of miR-155 and BIC RNA in human B cell lymphomas. |journal=Proc Natl Acad Sci U S A |volume=102 |issue=10 |pages=3627-32 |year=2005 |pmid=15738415}}</ref>
<ref name="pmid14695998">{{cite journal |author=Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A |title=High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. |journal=Genes Chromosomes Cancer |volume=39 |issue=2 |pages=167-9 |year=2004 |pmid=14695998}}</ref>
</div>
{{reflist|2}}


==External links==
==External links==


[http://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0000681 miRBase entry for mir-155]
[http://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0000681 miRBase entry for mir-155]
* {{Rfam|id=RF00731|name=mir-155 microRNA precursor family}}


[[Category:MicroRNA]]
[[Category:MicroRNA]]

Revision as of 12:49, 2 November 2010

mir-155
Identifiers
Symbolmir-155
RfamRF00731
miRBase familyMIPF0000157
Other data
RNA typemicroRNA
Domain(s)Eukaryota;
PDB structuresPDBe


In molecular biology, mir-155 microRNA is a short RNA molecule. MicroRNAs function to regulate the expression levels of other genes by a several mechanisms.


See also

Further reading

  1. ^ Huang RS, Hu GQ, Lin B, Lin ZY, Sun CC (2010). "MicroRNA-155 Silencing Enhances Inflammatory Response and Lipid Uptake in Oxidized Low-Density Lipoprotein-Stimulated Human THP-1 Macrophages". J Investig Med. PMID 21030878.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  2. ^ Ceolotto G, Papparella I, Bortoluzzi A, Strapazzon G, Ragazzo F, Bratti P, Fabricio AS, Squarcina E, Gion M, Palatini P, Semplicini A (2010). "Interplay Between miR-155, AT1R A1166C Polymorphism, and AT1R Expression in Young Untreated Hypertensives". Am J Hypertens. PMID 20966899.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  3. ^ Wang G, Tam LS, Li EK, Kwan BC, Chow KM, Luk CC, Li PK, Szeto CC (2010). "Serum and Urinary Cell-free MiR-146a and MiR-155 in Patients with Systemic Lupus Erythematosus". J Rheumatol. PMID 20952466.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  4. ^ Kutty RK, Nagineni CN, Samuel W, Vijayasarathy C, Hooks JJ, Redmond TM (2010). "Inflammatory cytokines regulate microRNA-155 expression in human retinal pigment epithelial cells by activating JAK/STAT pathway". Biochem Biophys Res Commun. PMID 20950585.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  5. ^ Imaizumi T, Tanaka H, Tajima A, Yokono Y, Matsumiya T, Yoshida H, Tsuruga K, Aizawa-Yashiro T, Hayakari R, Inoue I, Ito E, Satoh K (2010). "IFN-γ and TNF-α Synergistically Induce microRNA-155 Which Regulates TAB2/IP-10 Expression in Human Mesangial Cells". Am J Nephrol. 32 (5): 462–468. PMID 20948191.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  6. ^ {{cite journal |author=Thompson RC, Herscovitch M, Zhao I, Ford TJ, Gilmore TD |title=NF-{kappa}B down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway. |journal=J Biol Chem |volume= |issue= |pages= |year=2010 |pmid=20947507}}
  7. ^ Wang P, Hou J, Lin L, Wang C, Liu X, Li D, Ma F, Wang Z, Cao X (2010). "Inducible microRNA-155 Feedback Promotes Type I IFN Signaling in Antiviral Innate Immunity by Targeting Suppressor of Cytokine Signaling 1". J Immunol. PMID 20937844.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  8. ^ O'Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, Chaudhuri AA, Kahn ME, Rao DS, Baltimore D (2010). "MicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell Development". Immunity. 33 (4): 607–19. PMID 20888269.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  9. ^ Xia QS, Ishigaki Y, Zhao X, Shimasaki T, Nakajima H, Nakagawa H, Takegami T, Chen ZH, Motoo Y (2010). "Human SMG-1 is Involved in Gemcitabine-Induced Primary microRNA-155/BIC Up-Regulation in Human Pancreatic Cancer PANC-1 Cells". Pancreas. PMID 20871480.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  10. ^ Zhou H, Huang X, Cui H, Luo X, Tang Y, Chen S, Wu L, Shen N (2010). "miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells". Blood. PMID 20852130.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  11. ^ Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR (2010). "Virally Induced Cellular MicroRNA miR-155 Plays a Key Role in B-Cell Immortalization by Epstein-Barr Virus". J Virol. 84 (22): 11670–8. PMID 20844043.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  12. ^ Zheng L, Xu CC, Chen WD, Shen WL, Ruan CC, Zhu LM, Zhu DL, Gao PJ (2010). "MicroRNA-155 regulates angiotensin II type 1 receptor expression and phenotypic differentiation in vascular adventitial fibroblasts". Biochem Biophys Res Commun. 400 (4): 483–8. PMID 20735984.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  13. ^ Sonkoly E, Janson P, Majuri ML, Savinko T, Fyhrquist N, Eidsmo L, Xu N, Meisgen F, Wei T, Bradley M, Stenvang J, Kauppinen S, Alenius H, Lauerma A, Homey B, Winqvist O, StÃ¥hle M, Pivarcsi A (2010). "MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4". J Allergy Clin Immunol. 126 (3): 581-9.e1-20. PMID 20673989.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  14. ^ Tili E, Michaille JJ, Adair B, Alder H, Limagne E, Taccioli C, Ferracin M, Delmas D, Latruffe N, Croce CM (2010). "Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD". Carcinogenesis. 31 (9): 1561–6. PMID 20622002.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  15. ^ Boesch-Saadatmandi C, Loboda A, Wagner AE, Stachurska A, Jozkowicz A, Dulak J, Döring F, Wolffram S, Rimbach G (2010). "Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155". J Nutr Biochem. PMID 20579867.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  16. ^ Liu J, van Mil A, Vrijsen K, Zhao J, Gao L, Goumans MJ, Doevendans PA, Sluijter JP (2010). "MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1". J Cell Mol Med. PMID 20550618.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  17. ^ Pogribny IP, Starlard-Davenport A, Tryndyak VP, Han T, Ross SA, Rusyn I, Beland FA (2010). "Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice". Lab Invest. 90 (10): 1437–46. PMID 20548288.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  18. ^ Zhang Y, Diao Z, Su L, Sun H, Li R, Cui H, Hu Y (2010). "MicroRNA-155 contributes to preeclampsia by down-regulating CYR61". Am J Obstet Gynecol. 202 (5): 466.e1-7. PMID 20452491.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  19. ^ Hu YL, Fong S, Largman C, Shen WF (2010). "HOXA9 regulates miR-155 in hematopoietic cells". Nucleic Acids Res. 38 (16): 5472–8. PMID 20444872.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  20. ^ McCoy CE, Sheedy FJ, Qualls JE, Doyle SL, Quinn SR, Murray PJ, O'Neill LA (2010). "IL-10 inhibits miR-155 induction by toll-like receptors". J Biol Chem. 285 (27): 20492–8. PMID 20435894.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  21. ^ Yin Q, Wang X, Fewell C, Cameron J, Zhu H, Baddoo M, Lin Z, Flemington EK (2010). "MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivation". J Virol. 84 (13): 6318–27. PMID 20427544.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  22. ^ Zhu J, Hu XQ, Guo GL, Zhang Y, Wang OC, You J, Huang QD, Zhang XH (2010). "[Expression and its clinical significance of miR-155 in human primary breast cancer.]". Zhonghua Wai Ke Za Zhi. 48 (3): 205–8. PMID 20388420.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  23. ^ Kong W, He L, Coppola M, Guo J, Esposito NN, Coppola D, Cheng JQ (2010). "MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer". J Biol Chem. 285 (23): 17869–79. PMID 20371610.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  24. ^ Xia QS, Ishigaki Y, Sun L, Chen R, Motoo Y (2010). "[Effect of anti-cancer drugs on the expression of BIC/miR-155 in human pancreatic cancer PANC-1 cells]". Zhonghua Yi Xue Za Zhi. 90 (2): 123–7. PMID 20356498.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  25. ^ Jiang S, Zhang HW, Lu MH, He XH, Li Y, Gu H, Liu MF, Wang ED (2010). "MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene". Cancer Res. 70 (8): 3119–27. PMID 20354188.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  26. ^ Valeri N, Gasparini P, Fabbri M, Braconi C, Veronese A, Lovat F, Adair B, Vannini I, Fanini F, Bottoni A, Costinean S, Sandhu SK, Nuovo GJ, Alder H, Gafa R, Calore F, Ferracin M, Lanza G, Volinia S, Negrini M, McIlhatton MA, Amadori D, Fishel R, Croce CM (2010). "Modulation of mismatch repair and genomic stability by miR-155". Proc Natl Acad Sci U S A. 107 (15): 6982–7. PMID 20351277.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  27. ^ Ryu JK, Hong SM, Karikari CA, Hruban RH, Goggins MG, Maitra A (2010). "Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma". Pancreatology. 10 (1): 66–73. PMID 20332664.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  28. ^ Fabani MM, Abreu-Goodger C, Williams D, Lyons PA, Torres AG, Smith KG, Enright AJ, Gait MJ, Vigorito E (2010). "Efficient inhibition of miR-155 function in vivo by peptide nucleic acids". Nucleic Acids Res. 38 (13): 4466–75. PMID 20223773.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  29. ^ Tang B, Xiao B, Liu Z, Li N, Zhu ED, Li BS, Xie QH, Zhuang Y, Zou QM, Mao XH (2010). "Identification of MyD88 as a novel target of miR-155, involved in negative regulation of Helicobacter pylori-induced inflammation". FEBS Lett. 584 (8): 1481–6. PMID 20219467.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  30. ^ Fassi Fehri L, Koch M, Belogolova E, Khalil H, Bolz C, Kalali B, Mollenkopf HJ, Beigier-Bompadre M, Karlas A, Schneider T, Churin Y, Gerhard M, Meyer TF (2010). "Helicobacter pylori induces miR-155 in T cells in a cAMP-Foxp3-dependent manner". PLoS One. 5 (3): e9500. PMID 20209161.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  31. ^ Sidorkiewicz M, Grek M, Jozwiak B, Majda-Stanislawska E, Piekarska A, Bartkowiak J (2010). "Expression of microRNA-155 precursor in peripheral blood mononuclear cells from Hepatitis C patients after antiviral treatment". Acta Virol. 54 (1): 75–8. PMID 20201617.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  32. ^ Gueta K, Molotski N, Gerchikov N, Mor E, Savion S, Fein A, Toder V, Shomron N, Torchinsky A (2010). "Teratogen-induced alterations in microRNA-34, microRNA-125b and microRNA-155 expression: correlation with embryonic p53 genotype and limb phenotype". BMC Dev Biol. 10: 20. PMID 20170545.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  33. ^ Rai D, Kim SW, McKeller MR, Dahia PL, Aguiar RC (2010). "Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis". Proc Natl Acad Sci U S A. 107 (7): 3111–6. PMID 20133617.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  34. ^ Cremer TJ, Ravneberg DH, Clay CD, Piper-Hunter MG, Marsh CB, Elton TS, Gunn JS, Amer A, Kanneganti TD, Schlesinger LS, Butchar JP, Tridandapani S (2009). "MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine response". PLoS One. 4 (12): e8508. PMID 20041145.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  35. ^ Forrest AR, Kanamori-Katayama M, Tomaru Y, Lassmann T, Ninomiya N, Takahashi Y, de Hoon MJ, Kubosaki A, Kaiho A, Suzuki M, Yasuda J, Kawai J, Hayashizaki Y, Hume DA, Suzuki H (2010). "Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation". Leukemia. 24 (2): 460–6. PMID 19956200.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  36. ^ Pedersen IM, Otero D, Kao E, Miletic AV, Hother C, Ralfkiaer E, Rickert RC, Gronbaek K, David M (2009). "Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas". EMBO Mol Med. 1 (5): 288–95. PMID 19890474.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  37. ^ He M, Xu Z, Ding T, Kuang DM, Zheng L (2009). "MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta". Cell Mol Immunol. 6 (5): 343–52. PMID 19887047.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  38. ^ Tili E, Croce CM, Michaille JJ (2009). "miR-155: on the crosstalk between inflammation and cancer". Int Rev Immunol. 28 (5): 264–84. PMID 19811312.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  39. ^ Stahl HF, Fauti T, Ullrich N, Bopp T, Kubach J, Rust W, Labhart P, Alexiadis V, Becker C, Hafner M, Weith A, Lenter MC, Jonuleit H, Schmitt E, Mennerich D (2009). "miR-155 inhibition sensitizes CD4+ Th cells for TREG mediated suppression". PLoS One. 4 (9): e7158. PMID 19777054.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  40. ^ Bolisetty MT, Dy G, Tam W, Beemon KL (2009). "Reticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survival". J Virol. 83 (23): 12009–17. PMID 19759154.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  41. ^ Wang B, Majumder S, Nuovo G, Kutay H, Volinia S, Patel T, Schmittgen TD, Croce C, Ghoshal K, Jacob ST (2009). "Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice". Hepatology. 50 (4): 1152–61. PMID 19711427.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  42. ^ Pottier N, Maurin T, Chevalier B, Puisségur MP, Lebrigand K, Robbe-Sermesant K, Bertero T, Lino Cardenas CL, Courcot E, Rios G, Fourre S, Lo-Guidice JM, Marcet B, Cardinaud B, Barbry P, Mari B (2009). "Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions". PLoS One. 4 (8): e6718. PMID 19701459.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  43. ^ Xiao B, Liu Z, Li BS, Tang B, Li W, Guo G, Shi Y, Wang F, Wu Y, Tong WD, Guo H, Mao XH, Zou QM (2009). "Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response". J Infect Dis. 200 (6): 916–25. PMID 19650740.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  44. ^ Worm J, Stenvang J, Petri A, Frederiksen KS, Obad S, Elmén J, Hedtjärn M, Straarup EM, Hansen JB, Kauppinen S (2009). "Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c/ebp Beta and down-regulation of G-CSF". Nucleic Acids Res. 37 (17): 5784–92. PMID 19596814.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  45. ^ Costinean S, Sandhu SK, Pedersen IM, Tili E, Trotta R, Perrotti D, Ciarlariello D, Neviani P, Harb J, Kauffman LR, Shidham A, Croce CM (2009). "Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice". Blood. 114 (7): 1374–82. PMID 19520806.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  46. ^ Ruggiero T, Trabucchi M, De Santa F, Zupo S, Harfe BD, McManus MT, Rosenfeld MG, Briata P, Gherzi R (2009). "LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 precursors in macrophages". FASEB J. 23 (9): 2898–908. PMID 19423639.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  47. ^ Martinez-Nunez RT, Louafi F, Friedmann PS, Sanchez-Elsner T (2009). "MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN)". J Biol Chem. 284 (24): 16334–42. PMID 19386588.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  48. ^ O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D (2009). "Inositol phosphatase SHIP1 is a primary target of miR-155". Proc Natl Acad Sci U S A. 106 (17): 7113–8. PMID 19359473.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  49. ^ Faraoni I, Antonetti FR, Cardone J, Bonmassar E (2009). "miR-155 gene: a typical multifunctional microRNA". Biochim Biophys Acta. 1792 (6): 497–505. PMID 19268705.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  50. ^ Kohlhaas S, Garden OA, Scudamore C, Turner M, Okkenhaug K, Vigorito E (2009). "Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells". J Immunol. 182 (5): 2578–82. PMID 19234151.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  51. ^ Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA, Pierre P (2009). "MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells". Proc Natl Acad Sci U S A. 106 (8): 2735–40. PMID 19193853.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  52. ^ Habbe N, Koorstra JB, Mendell JT, Offerhaus GJ, Ryu JK, Feldmann G, Mullendore ME, Goggins MG, Hong SM, Maitra A (2009). "MicroRNA miR-155 is a biomarker of early pancreatic neoplasia". Cancer Biol Ther. 8 (4): 340–6. PMID 19106647.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  53. ^ Jung I, Aguiar RC (2009). "MicroRNA-155 expression and outcome in diffuse large B-cell lymphoma". Br J Haematol. 144 (1): 138–40. PMID 19016736.
  54. ^ Teng G, Papavasiliou FN (2009). "Shhh! Silencing by microRNA-155". Philos Trans R Soc Lond B Biol Sci. 364 (1517): 631–7. PMID 19008191.
  55. ^ Romania P, Lulli V, Pelosi E, Biffoni M, Peschle C, Marziali G (2008). "MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meis1 transcription factors". Br J Haematol. 143 (4): 570–80. PMID 18950466.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  56. ^ Zhao Y, Yao Y, Xu H, Lambeth L, Smith LP, Kgosana L, Wang X, Nair V (2009). "A functional MicroRNA-155 ortholog encoded by the oncogenic Marek's disease virus". J Virol. 83 (1): 489–92. PMID 18945769.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  57. ^ Gatto G, Rossi A, Rossi D, Kroening S, Bonatti S, Mallardo M (2008). "Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway". Nucleic Acids Res. 36 (20): 6608–19. PMID 18940871.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  58. ^ Rahadiani N, Takakuwa T, Tresnasari K, Morii E, Aozasa K (2008). "Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell lines". Biochem Biophys Res Commun. 377 (2): 579–83. PMID 18926796.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  59. ^ Kong W, Yang H, He L, Zhao JJ, Coppola D, Dalton WS, Cheng JQ (2008). "MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA". Mol Cell Biol. 28 (22): 6773–84. PMID 18794355.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  60. ^ Lu F, Weidmer A, Liu CG, Volinia S, Croce CM, Lieberman PM (2008). "Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence". J Virol. 82 (21): 10436–43. PMID 18753206.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  61. ^ Dorsett Y, McBride KM, Jankovic M, Gazumyan A, Thai TH, Robbiani DF, Di Virgilio M, San-Martin BR, Heidkamp G, Schwickert TA, Eisenreich T, Rajewsky K, Nussenzweig MC (2008). "MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation". Immunity. 28 (5): 630–8. PMID 18455451.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  62. ^ Teng G, Hakimpour P, Landgraf P, Rice A, Tuschl T, Casellas R, Papavasiliou FN (2008). "MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase". Immunity. 28 (5): 621–9. PMID 18450484.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  63. ^ Yin Q, McBride J, Fewell C, Lacey M, Wang X, Lin Z, Cameron J, Flemington EK (2008). "MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways". J Virol. 82 (11): 5295–306. PMID 18367535.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  64. ^ Zhang T, Nie K, Tam W (2008). "BIC is processed efficiently to microRNA-155 in Burkitt lymphoma cells". Leukemia. 22 (9): 1795–7. PMID 18354490.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  65. ^ Wang M, Tan LP, Dijkstra MK, van Lom K, Robertus JL, Harms G, Blokzijl T, Kooistra K, van T'veer MB, Rosati S, Visser L, Jongen-Lavrencic M, Kluin PM, van den Berg A (2008). "miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression". J Pathol. 215 (1): 13–20. PMID 18348159.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  66. ^ O'Connell RM, Rao DS, Chaudhuri AA, Boldin MP, Taganov KD, Nicoll J, Paquette RL, Baltimore D (2008). "Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder". J Exp Med. 205 (3): 585–94. PMID 18299402.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  67. ^ Rai D, Karanti S, Jung I, Dahia PL, Aguiar RC (2008). "Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma". Cancer Genet Cytogenet. 181 (1): 8–15. PMID 18262046.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  68. ^ Calame K (2007). "MicroRNA-155 function in B Cells". Immunity. 27 (6): 825–7. PMID 18093533.
  69. ^ Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi JT, Braich R, Manoharan M, Soutschek J, Ohler U, Cullen BR (2007). "A viral microRNA functions as an orthologue of cellular miR-155". Nature. 450 (7172): 1096–9. PMID 18075594.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  70. ^ Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, Kohlhaas S, Das PP, Miska EA, Rodriguez A, Bradley A, Smith KG, Rada C, Enright AJ, Toellner KM, Maclennan IC, Turner M (2007). "microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells". Immunity. 27 (6): 847–59. PMID 18055230.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  71. ^ Yin Q, Wang X, McBride J, Fewell C, Flemington E (2008). "B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element". J Biol Chem. 283 (5): 2654–62. PMID 18048365.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  72. ^ Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, Croce CM (2007). "Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock". J Immunol. 179 (8): 5082–9. PMID 17911593.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  73. ^ Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J, Garcia S, Nowak J, Yeung ML, Jeang KT, Chaix A, Fazli L, Motoo Y, Wang Q, Rocchi P, Russo A, Gleave M, Dagorn JC, Iovanna JL, Carrier A, Pébusque MJ, Dusetti NJ (2007). "Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development". Proc Natl Acad Sci U S A. 104 (41): 16170–5. PMID 17911264.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  74. ^ Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, Lopez MC, Baker HV, Renne R (2007). "Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155". J Virol. 81 (23): 12836–45. PMID 17881434.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  75. ^ Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS, Hatzigeorgiou AG, Antonarakis SE (2007). "Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes". Am J Hum Genet. 81 (2): 405–13. PMID 17668390.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  76. ^ Martin MM, Buckenberger JA, Jiang J, Malana GE, Nuovo GJ, Chotani M, Feldman DS, Schmittgen TD, Elton TS (2007). "The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microrna-155 binding". J Biol Chem. 282 (33): 24262–9. PMID 17588946.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  77. ^ Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, van Dongen S, Grocock RJ, Das PP, Miska EA, Vetrie D, Okkenhaug K, Enright AJ, Dougan G, Turner M, Bradley A (2007). "Requirement of bic/microRNA-155 for normal immune function". Science. 316 (5824): 608–11. PMID 17463290.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  78. ^ Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, Schmidt-Supprian M, Rajewsky N, Yancopoulos G, Rao A, Rajewsky K (2007). "Regulation of the germinal center response by microRNA-155". Science. 316 (5824): 604–8. PMID 17463289.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  79. ^ O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D (2007). "MicroRNA-155 is induced during the macrophage inflammatory response". Proc Natl Acad Sci U S A. 104 (5): 1604–9. PMID 17242365.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  80. ^ Martin MM, Lee EJ, Buckenberger JA, Schmittgen TD, Elton TS (2006). "MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts". J Biol Chem. 281 (27): 18277–84. PMID 16675453.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  81. ^ Chung KH, Hart CC, Al-Bassam S, Avery A, Taylor J, Patel PD, Vojtek AB, Turner DL (2006). "Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155". Nucleic Acids Res. 34 (7): e53. PMID 16614444.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  82. ^ Tam W, Dahlberg JE (2006). "miR-155/BIC as an oncogenic microRNA". Genes Chromosomes Cancer. 45 (2): 211–2. PMID 16252262.
  83. ^ Kluiver J, Haralambieva E, de Jong D, Blokzijl T, Jacobs S, Kroesen BJ, Poppema S, van den Berg A (2006). "Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma". Genes Chromosomes Cancer. 45 (2): 147–53. PMID 16235244.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  84. ^ Jiang J, Lee EJ, Schmittgen TD (2006). "Increased expression of microRNA-155 in Epstein-Barr virus transformed lymphoblastoid cell lines". Genes Chromosomes Cancer. 45 (1): 103–6. PMID 16175574.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  85. ^ Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S, Kroesen BJ, van den Berg A (2005). "BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas". J Pathol. 207 (2): 243–9. PMID 16041695.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  86. ^ Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, Lund E, Dahlberg JE (2005). "Accumulation of miR-155 and BIC RNA in human B cell lymphomas". Proc Natl Acad Sci U S A. 102 (10): 3627–32. PMID 15738415.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  87. ^ Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A (2004). "High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma". Genes Chromosomes Cancer. 39 (2): 167–9. PMID 14695998.{{cite journal}}: CS1 maint: multiple names: authors list (link)

External links

miRBase entry for mir-155

Stub icon

This genetics article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=MiR-155&oldid=394369234"